- Case report
- Open Access
A minute focus of extranodal marginal zone B-cell lymphoma arising in Hashimoto thyroiditis diagnosed with PCR after laser capture microdissection: a case report
© D'Antonio et al; licensee BioMed Central Ltd. 2009
- Received: 18 March 2009
- Accepted: 7 September 2009
- Published: 7 September 2009
Primary thyroid gland lymphomas are uncommon tumours that occur in the setting of lymphocytic thyroiditis or Hashimoto's disease in almost all cases. In this condition a distinction between an inflammatory lymphoid infiltrate and a low grade lymphoma may be extremely difficult and precise criteria are necessary for a correct diagnosis.
Patient and methods
We report a case of a minute focus of primary extranodal marginal zone B-cell lymphoma (EMZBCL), incidentally discovered in a 63-year-old man with Hashimoto thyroiditis (HT) and diagnosed by means of polymerase chain reaction (PCR) after laser capture microdissection.
The histological examination of surgical specimen confirmed the diagnosis of HT and showed a minute focus of dense lymphoid infiltrate (less than 4 mm in diameter), composed by centrocyte-like cells forming MALT balls. Immunoistochemistry was not useful. A microscopic focus of EMZBCL was suspected on the basis of morphological features. PCR assays revealed the rearrangement of the heavy chain of immunoglobulins only in the microdissected suspicious area, confirming the diagnosis of EMZBCL.
Our finding suggests that in cases of autoimmune thyroiditis a careful examination of the thyroid specimen is warranted, in order to disclose areas or small foci of lymphomatous transformation. Furthermore, in difficult cases with doubtful immunohistological findings, ancillary techniques, such as molecular studies, are necessary for a conclusive diagnosis.
- Thyroid Gland
- Polymerase Chain Reaction Assay
- Laser Capture Microdissection
- Autoimmune Thyroiditis
Extranodal marginal zone B-cell lymphoma (EMZBCL) mucosa-associated lymphoid tissue (MALT)-type frequently occurs in stomach, salivary glands, lung and breast. Primary involvement of thyroid gland is rare, usually arising in the setting of a lymphocytic thyroiditis [1–4].
In such cases, EMZBCL clinically appears as a gradual diffuse enlargement of the thyroid gland or as a slowly growing nodule in patients with long-standing Hashimoto thyroiditis (HT) . The diagnosis of EMZBCL in the background of a diffuse inflammatory lymphoid infiltrate may be extremely difficult on routinely examined histological sections. We report the case of a minute focus of EMZBCL of the thyroid gland, diagnosed by means of polymerase chain reaction (PCR) after laser capture microdissection (LCM).
A 63-year-old man presented with a clinical history of goiter and dysphagia. Physical evaluation revealed an enlarged and firm thyroid gland. No lymphadenopathy was recorded. The ultrasound scan showed a diffuse enlargement of the gland, with no calcification. The thyroid function tests showed a primary hypothyroidism with high serum titers of anti-thyroglobulin and anti-microsomal antibodies. One week after admission the patient underwent a total thyroidectomy because of increasing dyspnea and dysphagia.
Grossly, the thyroid gland was diffusely enlarged and showed a vaguely lobulated, pale, white-tan cut surface, with no macroscopic distinct nodules. Sections from paraffin-embedded tissue taken initially from 15 different levels of the gland parenchyma were examined.
25 more sections were taken from the surgical specimen, including all the areas macroscopically suggestive of lymphoid tissue, and histological examination on sections obtained from paraffin blocks at different levels did not show further areas or minute foci histologically consistent with lymphomatous transformation.
A minute focus of EMZBCL was suspected only on the basis of morphology.
Post-surgery general staging, including CT scan, did not document other pathological findings. A final diagnosis of primary EMZBCL MALT-type arising in HT was made. After surgery, the symptoms disappeared; the patient subsequently underwent only hormonal substitutive therapy and has been symptom-free for ten months.
EMZBCL is a low-grade lymphoma arising in MALT, originally described in the gastrointestinal tract, subsequently encountered in a variety of organs, such as lung, breast, salivary and lacrimal glands and thyroid [7–10]. In these sites, MALT appears as result of specific immune reactions or autoimmune disease [7–11].
In fact, lymphocytic thyroiditis or HT are almost certainly a requisite for development of EMZBCL in the thyroid gland . EMZBCL is an indolent tumour which tends to remain localized in the thyroid and the lymphomatous infiltrate is often focal in a background of thyroiditis. In these cases a distinction between EMZBCL and diffuse inflammatory lymphoid infiltrate may be extremely difficult and strict criteria are necessary for the differential diagnosis. Histologically, the presence of a dense lymphoid infiltrate with centrocyte-like cells forming MALT-balls may be suggestive but not specific of lymphoma. The presence of plasmacytoid cells with light chain immunoglobulin restriction is a very important finding for a diagnosis of lymphoma, but represents an inconstant feature. In difficult cases the molecular study for IgH gene rearrangements, demonstrating the B cell monoclonal nature of lymphoid cells, supports a correct diagnosis of lymphoma .
In our case the presence of a minute focus of 4-mm in diameter incidentally discovered after an extensive sampling of the entire thyroidectomy specimen represents an effective potential diagnostic pitfall.
PCR assays revealed the rearrangement of IgH only in the microdissected lymphomatous cells confirming the morphological diagnosis of EMZBCL.
The minute focus of EMZBCL, arising in HT and diagnosed by means of molecular assays, probably represents an early-stage in the development of a low-grade lymphoma strictly correlated to autoimmune thyroiditis. This appears an additional confirmation of the hypotesis that primary thyroid EMZBCL may evolve from HT [3, 12].
Thyroid EMZBCL is an indolent lymphoproliferative disorder and, when other localizations of disease can be excluded, total thyroidectomy, followed by radiotherapy when appropriate, represents a curative surgical treatment with a very good prognosis . Nevertheless, the disclosure of incidental lymphomatous areas is important to assure an accurate follow-up programme for the lymphoproliferative disease, as well as for autoimmune disorders.
The purpose of this report is to underline the difficulties in the formulation of a differential diagnosis, also for an experienced pathologist, in cases of lymphoma arising in a background of HT. Both morphology and immunohistochemistry can result ineffective. Nevertheless, also in presence of a disease incidentally discovered or with an indolent behaviour, the pathologist has the obligation to furnish a correct diagnosis. Then, in difficult cases with doubtful immunohistological findings, ancillary techniques, such as molecular studies, are necessary for a conclusive diagnosis.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL: Malignant lymphoma of thyroid gland. A clinicopathologic study of 108 cases. Am J Surg Pathol 2000, 24: 623–639. 10.1097/00000478-200005000-00001PubMedView ArticleGoogle Scholar
- Earnest LM, Cooper DS, Sciubba JJ, Tufano RP: Thyroid MALT lymphoma in patients with a compressive goiter. Head Neck 2006, 28: 765–770. 10.1002/hed.20424PubMedView ArticleGoogle Scholar
- Miller BS, Gauger PG: Thyroid lymphoma arising from Hashimoto's thyroiditis. J Clin Endocrinol Metab 2006, 91: 3711–3712. 10.1210/jc.2006-0786PubMedView ArticleGoogle Scholar
- Nakao A, Fujisawa K, Mimura H, Ezawa K, Natsumeda M, Fukuoka K, Isozaki H, Tanaka N: Mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid: report of a case. Anticancer Res 1999, 19: 811–814.PubMedGoogle Scholar
- Licci S, Canal F, Dei Tos AP, Fedrigo M, Gherlinzoni F, Brenna A, Zanatta L, Rossi S: Aleukemic granulocytic sarcoma with associated T-cell lymphoblastic lymphoma in the same lymph node: morphologic features and molecular signatures. Leuk Lymphoma 2008, 49: 1411–1415. 10.1080/10428190802108862PubMedView ArticleGoogle Scholar
- Theriault C, Galoin S, Valmary S, Selves J, Lamant L, Roda D, Rigal-Huguet F, Brousset P, Delsol G, Al Saati T: PCR analysis of immunoglobulin heavy chain (IgH) and TcR-. chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol 2000, 13: 1269–1279. 10.1038/modpathol.3880232PubMedView ArticleGoogle Scholar
- Ando M, Matsuzaki M, Murofushi T: Mucosa-associated lymphoid tissue lymphoma presented as diffuse swelling of the parotid gland. Am J Otolaryngol 2005, 26: 285–288. 10.1016/j.amjoto.2005.01.011PubMedView ArticleGoogle Scholar
- Kohmo S, Tachibana I, Osaki T, Goya S, Matsuoka H, Kijima T, Yoshida M, Kumagai T, Ikeda J, Aozasa K, Kawase I: Multiple organ mucosa-associated lymphoid tissue lymphoma presenting with lymphangitic pattern of spread in the lung. J Thorac Oncol 2007, 2: 1057–1059. 10.1097/JTO.0b013e318158ef26PubMedView ArticleGoogle Scholar
- Makola D, Peura DA, Crowe SE: Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol 2007, 41: 548–558. 10.1097/MCG.0b013e318030e3c3PubMedView ArticleGoogle Scholar
- Taeda Y, Ariga N, Okamura K, Takei N, Komeno T, Ueki H, Ohtani H: Primary breast mucosa-associated lymphoid tissue (MALT) lymphoma with high-grade transformation evidenced by prominent lymphoepithelial lesions. Breast Cancer 2006, 13: 322–327. 10.2325/jbcs.13.322PubMedView ArticleGoogle Scholar
- Cavalli F, Isaacson PG, Gascoyne RD, Zucca E: MALT Lymphomas. Hematology Am Soc Hematol Educ Program 2001, 241–258.Google Scholar
- Moshynska OV, Saxena A: Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol 2008, 61: 438–444. 10.1136/jcp.2007.051243PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.